Added to Your Shopping Cart
Certificate of Analysis
Are you looking for...
You might be interested in...
Type in Product name, Keyword or Catalog number to see suggestions.
Looking for a Certificate of Analysis?
Have your catalog and lot numbers ready and click the link.
Find CoA
You searched for "Custom Media and Process Development"
Too many choices? Use the filter option on the left to narrow your product listing.
Compare
TheraPEAK 293-GT® Media System
Catalog #: BP18-971
Flexible media system for gene therapy process development and high-titer AAV production in HEK293 cells
Compare
TheraPRO® CHO Cloning Medium - 1L
Catalog #: BESP1609Q
Chemically defined, non-animal origin (NAO), serum-free medium
Compare
TheraPEAK® SfAAV® Medium
Catalog #: BP12-945Q
TheraPEAK® SfAAV® Medium for AAV production in SF9 cells, chemically defined, hydrolysate free, 1 L
Compare
TheraPEAK® T-VIVO® Cell Culture Medium 1L bag
Catalog #: BP08-970Y
TheraPEAK® T-VIVO® Cell Culture Medium, chemically defined, non-animal origin (NAO), serum-free, with recombinant proteins, 1 L bag
Compare
TheraPEAK® T-VIVO® Cell Culture Medium 1L bottle
Catalog #: BP12-970Q
TheraPEAK® T-VIVO® Cell Culture Medium, chemically defined, non-animal origin (NAO), serum-free, with recombinant proteins, 1 L bottle
Compare
20 L Platinum UltraPAKTM Bioprocess container, 20/case
Catalog #: 08-E1325
20 L Platinum UltraPAKTM Bioprocess container
Added to Your Shopping Cart
-
MDL - Customer Facing Presentation - AssetCustomer Facing Deck - Custom Media Solutions
-
MDL - Customer Facing Presentation - AssetCustomer Facing Deck - Custom Media Solutions
-
End-to-end custom media and buffer solutionsBrochure on 3PIP, MDL and buffers
-
3PIP MDL - Asset - InfographicAn infographic illustrating Lonza’s end‑to‑end custom media and buffer solutions for CHO cells.
-
End-to-end process scalability of HEK 293 media for high titer AAV productionLearn how our TheraPEAK® 293-GT Media Platform supports end-to-end acceleration of AAV development programs from small scale workflows through to manufacturing.
-
CD34+ Cells for Cell and Gene Therapy Process DevelopmentIn this interview Dr. Manon Destalminil, Bioprocessing Project Leader at CellProthera, discusses the advantages of using research-grade CD34+ cells for cell and gene therapy process development. Please register to read.
-
CellBio Services – Custom Solutions to Meet Your Unique Research NeedsBrochure showcasing Lonza's CellBio Services capabilities including cell isolations and expansions, research grade media production, transfection services, and cell characterization.
-
Streamlining Your QC Testing: Automated Endotoxin Testing and Process OptimizationLearn how automating the liquid handling aspect of the endotoxin test helps you save time and reduce manual pipetting errors and retests. -
TheraPRO CHOK1 presentationPresentation on TheraPRO CHOK1 for prospects and customers
-
Evaluation of an Online PAT Co-Laboratory for Rapid Process Development: A Takeda Use StudyEvaluation of an Online PAT Co-Laboratory for Rapid Process Development – A Takeda use study Attendees will learn how to accelerate process development using the MAST® Automated Sampling System: • Automated process developed using a cross functional team with upstream and downstream engineers and analytical scientists • Measured product quality attributes including titer, aggregation, charge variants and post-translational modifications • Resulted in 10-fold reduction in total analytical time • Reduced FTE required by 65%
Product Availability by Store Location
Hours